Growing old in China in socioeconomic and epidemiological context: systematic review of social care policy for older people

Abstract

Background From 2020 to 2050, China’s population aged ≥65 years old is estimated to more than double from 172 million (12·0%) to 366 million (26·0%). Some 10 million have Alzheimer’s disease and related dementias, to approach 40 million by 2050. Critically, the population is ageing fast while China is still a middle-income country. Methods Using official and population-level statistics, we summarise China’s demographic and epidemiological trends relevant to ageing and health from 1970 to present, before examining key determinants of China’s improving population health in a socioecological framework. We then explore how China is responding to the care needs of its older population by carrying out a systematic review to answer the question: ‘what are the key policy challenges to China achieving an equitable nationwide long-term care system for older people?’. Databases were screened for records published between 1st June 2020 and 1st June 2022 in Mandarin Chinese or English, reflecting our focus on evidence published since introduction of China’s second long-term care insurance pilot phase in 2020. Results Rapid economic development and improved access to education has led to widescale internal migration. Changing fertility policies and household structures also pose considerable challenges to the traditional family care model. To deal with increasing need, China has piloted 49 alternative long-term care insurance systems. Our findings from 42 studies (n = 16 in Mandarin) highlight significant challenges in the provision of quality and quantity of care which suits the preference of users, varying eligibility for long-term care insurance and an inequitable distribution of cost burden. Key recommendations include increasing salaries to attract and retain staff, introduction of mandatory financial contributions from employees and a unified standard of disability with regular assessment. Strengthening support for family caregivers and improving smart old age care capacity can also support preferences to age at home. Conclusions China has yet to establish a sustainable funding mechanism, standardised eligibility criteria and a high-quality service delivery system. Its long-term care insurance pilot studies provide useful lessons for other middle-income countries facing similar challenges in terms of meeting the long-term care needs of their rapidly growing older populations.

Association of changes in waist circumference, waist-to-height ratio and weight-adjusted-waist index with multimorbidity among older Chinese adults: results from the Chinese longitudinal healthy longevity survey (CLHLS)

“…The ageing process has accelerated in recent decades, and it is expected that the number of people aged 65 and above in China will increase from 172 million to 366 million from 2020 to 2050, accounting for 26.0% of the total population [ 1 ]. Aging is associated with increased susceptibility to many diseases, which can clinically lead to multimorbidity.…”

Tracking Chinese Online Activity and Interest in Osteoporosis Using the Baidu Index

“…The situation of osteoporosis in middle-aged and elderly people is grim due to the acceleration of aging, and the number of elderly people suffering from osteoporosis is increasing [ 3 ]. With the acceleration of urbanization and population aging in China and the widespread prevalence of unhealthy lifestyles, the prevention and control of osteoporosis in China is becoming increasingly grim [ 4 , 5 ].…”

Digital computerised cognitive training for preventing cognitive decline among hypertensive patients: a study protocol for a multicentre randomised controlled trial (DELIGHT trial)

“…It was estimated that the number of people aged 65 and above would double from 172 million (12.0%) in 2020 to 366 million (26.1%) in 2050. 1 In this increasingly ageing Chinese population, cognitive decline has become a significant public health concern. 2 Hypertension, as one of the leading causes of morbidity and mortality worldwide, 3 is a significant risk factor for cognitive impairment, including mild cognitive impairment (MCI), Alzheimer’s disease (AD) and vascular dementia.…”